Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Revenue

Betta Pharmaceuticals had revenue of 1.04B CNY in the quarter ending March 31, 2026, with 13.33% growth. This brings the company's revenue in the last twelve months to 3.73B, up 21.40% year-over-year. In the year 2025, Betta Pharmaceuticals had annual revenue of 3.61B with 24.81% growth.

• Revenue (ttm): 3.73B
• Revenue Growth: +21.40%
• P/S Ratio: 5.51
• Revenue / Employee: 2.09M
• Employees: 1,785
• Market Cap: 20.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.61B	717.39M	24.81%
Dec 31, 2024	2.89B	435.75M	17.74%
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error